Dopaminergic Control of Thyrotropin, a-Subunit, Thyrotropin β-subunit, and Prolactin in Euthyroidism and Hypothyroidism: Dissociated Responses to Dopamine Receptor Blockade with Metoclopramide in Hypothyroid subjects*
- 1 August 1981
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 53 (2), 360-365
- https://doi.org/10.1210/jcem-53-2-360
Abstract
Thirteen female patients (ages 29-68 yr) with primary hypothyroidism and 10 euthyroid volunteers (5 females and 5 males, ages 22-43 yr) each received a single 10-mg dose of the dopamine-receptor blocking drug, metoclopramide. Intact TSH, PRL, α-subunit, and β-TSH responses over a 3-h period after drug administration have been compared with circulating hormone levels after placebo. In euthyroid subjects, intact TSH and a-subunit showed clear rises after metoclopramide compared with placebo (mean total incremental changes ± SE: intact TSH, 7.1 ± 1.3 vs. −3.4 ± 1.3 mU/liter. P < 0.001; a-subunit, 0.9 ± 0.2 us. −1.3 ± 0.6 ng/ml. P < 0.001). β-TSH changes, however, did not differ significantly from placebo (0.4 ± 0.5 vs. 1.1 ± 0.5 ng/ml, not significant). Total incremental responses (mean ± SE) were very much greater in hypothyroid than in euthyroid subjects for intact TSH (35.6 ± 9.8 vs. 7.1 ± 1.3 mU/liter, P < 0.001), a-subunit (7.2 ± 1.4 vs. 0.9 ± 0.2 ng/ml, P < 0.001), and β-TSH (6.5 ± 2.2 vs. 0.4 ± 0.5 ng/ ml, P< 0.001). Within the hypothyroid group the total incremental intact TSH responses (mean ± SE) were significantly less in patients with T4 less than 50 nmol/liter than in patients with T4 levels greater than 50 nmolliter (4.0 ± 7.7 vs. 52.5 ± 12.6 mU/liter, P < 0.02). In contrast, total incremental PRL, a-subunit, and β-TSH responses did not differ significantly between hypothyroid patients with T4 less than 50 nmol/liter (PRL, 27.7 ± 8.0 mU/ liter; a-subunit, 8.5 ± 3.2 ng/ml; β-TSH, 3.2 ± 1.9 ng/ml) and those with T4 levels greater than 50 nmol/liter (PRL, 45.2 ± 5.8 nU/liter; a-subunit, 6.4 ± 1.1 ng/nl; β-TSH, 8.5 ± 3.3 ng/ml). However, /8-TSH responses correlated directly with intact TSH responses in hypothyroid subjects (r = 0.63; P < 0.05), whereas PRL and a-subunit responses were not significantly related to the intact TSH response. Again in hypothyroid subjects, the PRL response was inversely related to subject age (r = −0.76; P < 0.05), whereas the intact TSH, a-subunit, and β-TSH responses were unrelated to subject age. We conclude from these data that, as with intact TSH, α-subunit and β-TSH release is under inhibitory dopaminergic control. Subunit release after dopamine antagonism is seen most clearly in hypothyroid subjects in whom the dominant negative feedback effects of thyroid hormones are reduced. The intact TSH response to dopamine antagonism and hence the dopami-nergic inhibition of intact TSH release declines with increasingly severe hypothyroidism. Intact TS H responses in hypothyroid subjects are paralleled by β-TSH responses, whereas PRL and a-subunit responses are not so clearly related to intact TSH responses and thyroid status.Keywords
This publication has 6 references indexed in Scilit:
- Influence of Thyroid Status on Dopaminergic Inhibition of Thyrotropin and Prolactin Secretion: Evidence for an Additional Feedback Mechanism in the Control of Thyroid Hormone SecretionJournal of Clinical Endocrinology & Metabolism, 1980
- Thyrotropin: α- and β-Subunits of Thyrotropin, and Prolactin Responses to Four-Hour Constant Infusions of Thyrotropin-Releasing Hormone in Normal Subjects and Patients with Pituitary-Thyroid Disorders*Journal of Clinical Endocrinology & Metabolism, 1979
- DOPAMINE IS A PHYSIOLOGICAL REGULATOR OF THYROTROPHIN (TSH) SECRETION IN NORMAL MANClinical Endocrinology, 1979
- INCREASED PROLACTIN AND THYROTROPHIN SECRETION FOLLOWING ORAL METOCLOPRAMIDE: DOSE-RESPONSE RELATIONSHIPSClinical Endocrinology, 1977
- Metabolic clearance and secretion rates of subunits of human thyrotropin.JCI Insight, 1977
- Homologous radioimmunoassay for human prolactinInternational Journal of Nuclear Medicine and Biology, 1976